Doctor profile · Federal record
Dr. Jay Ghadiali, M.D.
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Philadelphia, PA
- NPI 1053760835
- Accepts Medicare
- 10 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3400 Spruce St
Philadelphia, PA 191044238
(215) 662-2454
Credentials & registration
- NPI registered
- June 2016 — 10 yrs on file
- Profile last updated
- February 20, 2020
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #MT210707
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053760835. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,304
Distinct HCPCS
10
Medicare allowed
$320,779
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 9,030 | 13 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 4,560 | 57 | $23 | |
J3489 |
Injection, zoledronic acid, 1 mg | 371 | 75 | $9 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 273 | 159 | $127 | |
96372 |
Injection of drug or substance under skin or into muscle | 258 | 89 | $14 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 175 | 30 | $1 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 146 | 94 | $179 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 130 | 130 | $220 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 82 | 16 | $133 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 74 | 74 | $65 |
In context: peer comparison
Among 31 peers in Philadelphia Rheumatology Physician, average services per provider: 860. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$2,633
Transactions
89
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 20 | $694.87 | |
| Amgen INC. | 11 | $246.05 | |
| AstraZeneca Pharmaceuticals Lp | 5 | $204.34 | |
| Janssen Biotech, INC. | 5 | $189.26 | |
| Genentech USA, INC. | 7 | $165.36 | |
| Fresenius Kabi USA, LLC | 9 | $137.80 | |
| Ucb, INC. | 7 | $133.77 | |
| Lilly USA, LLC | 4 | $97.06 | |
| Pfizer INC. | 4 | $96.80 | |
| Ani Pharmaceuticals, INC. | 4 | $81.95 | |
| Organon LLC | 3 | $80.93 | |
| Sandoz INC. | 4 | $76.28 | |
| Alexion Pharmaceuticals, INC. | 2 | $68.31 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $59.06 | |
| Novartis Pharmaceuticals Corporation | 2 | $51.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
765
Patients
246
Total drug cost
$18,994
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 320 | 83 | $2,864 |
| Methotrexate (Methotrexate Sodium) | Brand | 108 | 47 | $4,365 |
| Alendronate Sodium | Generic | 71 | 23 | $1,000 |
| Hydroxychloroquine Sulfate | Generic | 70 | 33 | $6,157 |
| Allopurinol | Generic | 67 | 17 | $1,170 |
| Meloxicam | Generic | 28 | 15 | $174 |
| Methylprednisolone | Generic | 24 | 17 | $200 |
| Colchicine | Generic | 21 | 0 | $1,744 |
| Tramadol Hcl | Generic | 19 | 0 | $169 |
| Leflunomide | Generic | 13 | 11 | $587 |
Hospital affiliations
Frequently asked questions
What is Dr. Jay Ghadiali's medical specialty?
Dr. Jay Ghadiali practices Rheumatology Physician in Philadelphia, PA.
Where does Dr. Jay Ghadiali practice?
Dr. Jay Ghadiali practices at 3400 Spruce St, Philadelphia, PA 191044238. Office phone: 2156622454.
What is Dr. Jay Ghadiali's NPI?
Dr. Jay Ghadiali's National Provider Identifier (NPI) is 1053760835, issued by NPPES.
Does Dr. Jay Ghadiali accept Medicare assignment?
Yes. Dr. Jay Ghadiali accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jay Ghadiali commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Injection, zoledronic acid, 1 mg (HCPCS J3489). Source: CMS Medicare Physician & Other Practitioners file.